./start_session --force

Molecular Reality Corporation

Problem: No Utility for Molecular Reality

• Molecular data is scarce, siloed, and expensive; most high-quality signals come from professional labs running narrow, target-specific assays.
• Existing platforms (qPCR, mass spec, ELISA, next-gen sequencing, biological nanopores) are powerful but fragile, reagent-bound, and not suited for deployment in plumbing, HVAC, or consumer hardware at global scale.
• Pore-based sensing can be used to "see" (discover, characterize, measure, count, identify) virtually anything that can be suspended in solution, from single atoms, small molecules, polymers, viruses, to cells, and beyond, making it well-suited as an approach to utility-scale molecular sensing—but progress has been slow due to cost, tedium, and lack of coordination.

Core Thesis

• Universal, label-free molecular identification will not be solved by a single heroic lab; it requires Apollo Project–scale exploration of pore materials, geometries, voltages, buffers, analytes, translocation control strategies, and sensing modalities.
• The only tractable way to explore this combinatorial space is a distributed, standardized, solid-state platform generating massive, diverse, open datasets for machine learning models trained directly on raw data.
• The MR1 Molecular Streaming Device plus Epic Quest Bio™ is that platform: thousands of identical instruments, coordinated, gamified experiments, and a unified data pipeline to train a single Molecular World Model.

Platform: MR1 Molecular Streaming Device

Handheld, solid-state Coulter / nanopore hybrid for resistive pulse sensing over ~pA–µA current ranges; 1–100 µm pores initially, roadmap down to nanometer-scale ss-nanopores.

[Electronics stack]

• ESP32‑S3 MCU for control, streaming, on-device preprocessing.
• LMP7721 ultra‑low input bias current transimpedance preamp for picoampere resolution.
• MAX11169 16‑bit ADC, 10–125 kS/s effective sampling for ionic current traces.
• MCP4822 DAC plus TL3541 op‑amps for precise bias control and fast polarity switching (ping-pong).
• Four-layer FR‑4 PCB with separated analog/digital domains, star-ground, and Faraday integration points for low noise.

[Flow-cell architecture]

• Replaceable cartridges with silicon micropores (Bosch DRIE, native oxide) in first wave; aspect ratios and diameters spanning hundreds of nanometers to tens of microns.
• Roadmap pores: SiN, SiO₂, Al₂O₃, HfO₂, TiO₂, few-layer and monolayer graphene, MoS₂, WS₂, h‑BN, polymers (PET, polycarbonate, polyimide, PDMS, polyurethane, Teflon), glasses (borosilicate, fused silica, quartz), sapphire/ruby, etc.
• Integrated Ag/AgCl electrodes; mechanical provisions for future multi-pore arrays with independent electrical addressing and sliding-aperture selection.

Maxine's Quest

Originally built for the demonpore 64, Maxine's Quest is a platform for molecular games. It's also control software for the MR series of molecular streaming devices.

Here's a 15-second sizzle reel showing early game play:

Science Roadmap

Phase 1 (current):
Micron-scale particles and cells; Coulter-counter replication, flow optimization, SNR benchmarking vs. benchtop systems. Parameter sweeps across pore size, voltage, salt, buffer, and sample classes; open data for early ML models.

Years 2–3:
Push to viral-scale and protein-scale analytes. Initiate serious solid-state DNA sequencing attempts; target 0.1–10 bases/s now → 1 base/ms discrimination with SNR ≥ 15. Begin multi-analyte classification in complex mixtures via supervised/unsupervised models on accumulated time-series traces.

Years 4–5:
Advanced MR series devices with CMOS-integrated arrays (10³–10⁶ pores/chip), multi-modal detection (longitudinal current + transverse tunneling/optical/plasmonic where appropriate). First “universal diagnostic” prototypes: label-free identification of broad analyte classes without target-specific reagents.

Years 5–10:
Infrastructure deployment: smart toilets, sinks, and HVAC in buildings; continuous passive monitoring of human and environmental molecular flux, with orders of magnitude greater depth than the world collectively achieves in the mid-2020s.

Key Technical Innovations

• Mechanical nanopores (sliding occlusion)
  Laterally movable overlapping apertures enabling real-time, mechanical control of effective pore cross-section. Translocation slowdown, analyte capture, and oversampling by dynamically constricting the ionic path; complementary to electrokinetic ping-pong control.
• Ping-pong translocation control
  Fast voltage polarity switching to shuttle individual particles back-and-forth through the sensing zone, dramatically increasing effective sampling per analyte. Design (stretch) goal: sub-cubic-angstrom volumetric precision for size/shape inference, extending results like Edwards et al. 2015 to commodity hardware.
• Galaxy-of-pores strategy
  Systematic exploration of a matrix of: substrate materials, membrane thickness, pore diameter/shape, surface functionalization, buffer composition, temperature, bias waveform, and flow geometry. Standardized cartridges at pennies per flow cell enable massive A/B testing across thousands of users—something no single lab can replicate.
• Molecular World Model
  Raw data: high-rate ionic current time series with precise metadata (pore ID, material, geometry, chemistry, voltage protocol, sample provenance). Models: transformer architectures and deep RL agents optimizing experimental control (voltage, flow, aperture, buffer) for discriminability and throughput. Objective: device-level single-analyte universality—one compact platform spanning ions → macromolecules → cells with unified inference.

Distributed Research Methodology

• Epic Quest Bio™
  Thousands of Player Scientists™ operating standardized MR series devices under coordinated, gamified protocols. Experiments encoded as missions within Maxine’s Quest™; gameplay tightly coupled to calibration tasks, parameter sweeps, and sample diversity objectives. Reward structure (XP → advisory equity) aligned to data quality, novelty (Unidentified Signal Producing Events, USPEs), protocol optimization, and community contributions (code, cartridges, analyses).
• World Particle Project
  Global mapping of USPEs from environmental, clinical, agricultural, and household samples. GPS-tagged, time-stamped data enabling longitudinal and spatial correlation between unknown signals and known phenotypes and environments.
• Validation
  Cross-user reproducibility metrics using shared reference samples and calibration protocols. Orthogonal benchmarking against qPCR, mass spectrometry, and established diagnostics on defined analyte panels. Open data and open algorithms for external verification and community-driven methods improvements.

Solid-State vs. Biological Nanopores

Background, Ethos, Raison d'être

• Deep ss-nanopore experience
  Originated as demonpore, inc.; years of prior work on solid-state nanopores, mechanical translocation control, and custom pore arrays. Hands-on fabrication and testing across dozens of pore materials and geometries, including novel mechanical sliding-occlusion structures.
• Integrated hardware–software–community stack
  In-house design of MR series electronics, firmware, cartridges, and control software; no dependence on fragile biological components. Gamified experimental orchestration (Maxine’s Quest) that turns calibration and parameter sweeps into an engaging, large-scale optimization engine.
• Radical openness as strategic advantage
  Open-source hardware, firmware, and protocols; all inventions committed to the public domain. Aggressive defensive publication to prevent IP lock-up and enable a de facto standard for solid-state molecular streaming.
• Mission-level alignment
  Explicit focus on utility-scale sensing and disease/aging interventions—not just publishing incremental nanopore papers or selling isolated instruments. Business model centered on data, algorithms, and infrastructure, with MR series as dev kits.

Applications (Roadmap)

• Near term (MR1 + early upgrades)
  Coulter-style cell counting and size distribution. Environmental monitoring: water, wastewater, soil extracts, bioaerosol condensates. Food and beverage analysis, spoilage tracking, process monitoring.
• Medium term
  Viral and bacterial detection and classification in complex matrices. Protein-level sensing, conformational dynamics, enzyme kinetics in simplified systems. Microbiome signature profiling (e.g., gut, skin, environmental microbiota).
• Long term
  Solid-state DNA and protein sequencing; epigenetic marks and modified nucleotides. Point-of-use diagnostics embedded in residential and clinical plumbing: early detection of infection, cancer, metabolic disorders, and aging biomarkers. Population-scale longitudinal molecular phenotyping enabling personalized medicine and real-time epidemiology.

Ethics, Privacy, and Governance

Acknowledges that utility-scale molecular sensing will make many biological secrets legible; treats this as a serious unsolved problem.

Data policies: early-stage open, non-anonymized research data, transitioning to privacy-preserving protocols as clinical power increases (MR3+).

Governance vision: community co-ownership via XP→equity pipeline; emphasis on shared tools, open data, and distributed credit to avoid extractive, centralized control of molecular information.

Contact